Healthcare-associated infections – a threat to patient safety in Europe A total of 8.9 million HAIs were estimated to occur each year in European hospitals and long-term care facilities Lisateave
Antimicrobial use in: Long-term care facilities 7 / 10 antimicrobials were prescribed for treatment of an infection and 3 in 10 for prophylaxis. Lisateave
Antimicrobial use in European hospitals and long-term care facilities 1 in 3 patients received at least one antimicrobial on any given day. Some of this use may be unnecessary and contribute to the spread of antimicrobial resistance. Lisateave
Antibiotic resistance – an increasing threat to human health Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden is comparable to that of influenza, tuberculosis and HIV/AIDS combined. Lisateave
We work together to fight antibiotic resistance - Keeping Europeans healthy How do EU agencies contribute to the fight against antimicrobial resistance? See a joint EMA/ECDC/EFSA/EEA infographic Lisateave
Antibiootikumid - kasutage vastutustundlikult Infograafikul selgitatakse, mis on antibiootikumiresistentsus ja selle probleemid seoses inimeste antibiootikumikasutusega haiglates ja mujal. Lisateave
Kuidas antibiootikumiresistentsus levib? See infograafik selgitab, kuidas antibiootikumiresistentsus levib loomakasvatuses, kogukonnas, tervishoiuasutustes ja reisimisel. Lisateave
Antimikroobne resistentsus Euroopas: 2014 2014. aastal avaldatud ülevaade antimikroobse resistentsuse andmetest Euroopas Lisateave
Kasvav resistentsus viimase valiku antibiootikumide suhtes: 2013 Karbapeneemid on üks peamisi viimase valiku antibiootikumide klasse, mida kasutatakse bakterinfektsioonide raviks. Lisateave
